Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Childhood Brain Tumors: Molecular Marker to Facilitate Prognosis and Treatment Planning

06.12.2005


Valuable results for the complex jigsaw puzzle of cancer development



CDK6 is the plain name of a molecule that is often characteristically altered in medulloblastoma. This type of cancer is among the most common malignant brain tumors in children. Heidelberg molecular geneticians of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now found out that CDK6 can serve as an important indicator to help physicians determine the prognosis of patients. The results obtained in a project of the National Genome Research Network within the Brain Tumor Network have been published in the latest issue of the Journal of Clinical Oncology.

The typical age at the onset of medulloblastoma is seven years. Frequently, the tumor has already spread to other parts of the body. Despite intensive treatment almost half of the young patients die of this cancer. To be able to evaluate the course of such a tumor disease based on characteristic molecular markers and to develop novel treatment strategies, cancer researchers are trying to elucidate the development of the disease.


Frank Mendrzyk and Dr. Bernhard Radlwimmer of the Molecular Genetics Division have now contributed an important puzzle piece. The two researchers used the matrix-CGH technology developed by their divisional head Professor Peter Lichter to identify genetic alterations in medulloblastoma. Working with tissue samples of brain tumors they started by searching the whole genome for overrepresented and underrepresented segments of genetic material. Then they used immunological detection methods to investigate how identified candidate genes of these regions and their products are interconnected with the stage and course of the disease. This study was based on tumor tissue obtained from more than 200 patients whose medical records are known. The investigators found out that an increased number of gene copies is associated with overproduction of CDK6 and an unfavorable course of the disease. The gene located on chromosome 7 appears to play a key role in signaling pathways influencing growth and differentiation of medulloblastoma cells and other tumor cells. Compared to previously available markers, CDK6 seems to be an independent and at the same time more reliable source of information. Moreover, the gene product is easy to detect with immunological methods that are already established in routine diagnostics. CDK6 is also useful in clinical trials when it comes to evaluating the response to a treatment strategy.

The molecular geneticians have even more valuable findings to present. A factor called PPM1D is typically overproduced in medulloblastoma due to amplification of DNA segments on chromosome 17. The gene is not unknown to scientists. It is also found in multiple copies in neuroblastoma as well as in breast and ovarian cancer. Earlier publications have presented evidence suggesting that these alterations of the genetic information play a role in cancer development. Thus, other scientists showed in mouse embryonic cells that PPM1D is capable of abrogating the function of tumor suppressor gene TP53. TP53, jointly with other genes, regulates cell multiplication and thus reduces the likelihood of a cell turning into a tumor cell. Conversely, cells were resistant to transformation when they lacked PPM1D.

Further analyses and functional studies need to be performed in order to understand the exact role these genes play in the development of medulloblastoma. Eventually, cancer researchers are hoping to use this knowledge to find new targets for therapies and thus positively influence the course of the disease.

The task of the Deutsches Krebsforschungszentrum in Heidelberg (German Cancer Research Center, DKFZ) is to systematically investigate the mechanisms of cancer development and to identify cancer risk factors. The results of this basic research are expected to lead to new approaches in the prevention, diagnosis and treatment of cancer. The Center is financed to 90 percent by the Federal Ministry of Education and Research and to 10 percent by the State of Baden-Wuerttemberg. It is a member of the Helmholtz Association of National Research Centers (Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V., HGF).

Julia Rautenstrauch | alfa
Further information:
http://www.dkfz.de/en/genetics/index.html

More articles from Life Sciences:

nachricht Enduring cold temperatures alters fat cell epigenetics
19.04.2018 | University of Tokyo

nachricht Full of hot air and proud of it
18.04.2018 | University of Pittsburgh

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

Im Focus: The Future of Ultrafast Solid-State Physics

In an article that appears in the journal “Review of Modern Physics”, researchers at the Laboratory for Attosecond Physics (LAP) assess the current state of the field of ultrafast physics and consider its implications for future technologies.

Physicists can now control light in both time and space with hitherto unimagined precision. This is particularly true for the ability to generate ultrashort...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Diamond-like carbon is formed differently to what was believed -- machine learning enables development of new model

19.04.2018 | Materials Sciences

Electromagnetic wizardry: Wireless power transfer enhanced by backward signal

19.04.2018 | Physics and Astronomy

Ultrafast electron oscillation and dephasing monitored by attosecond light source

19.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>